Publication:
The future of surgical aortic valve replacement and the role of sutureless technology

dc.contributor.authorsIsbir, Selim
dc.date.accessioned2022-03-10T15:25:26Z
dc.date.accessioned2026-01-10T19:06:37Z
dc.date.available2022-03-10T15:25:26Z
dc.date.issued2018
dc.description.abstractAortic valve stenosis has become the most frequent type of valve disease in worldwide. Surgical aortic valve replacement is still the gold standard therapy. More recently transcatheter aortic valve implantation has been demonstrated to be not inferior in patients with high and intermediate risk patients. Sutureless aortic valves were designed to simplify the surgical aortic valve replacement. With the aid of this new technology, the invasiveness of surgery can be reduced with potential improvements in outcome.
dc.identifier.doi10.23736/S0026-4725.17.04550-9
dc.identifier.eissn1827-1618
dc.identifier.issn0026-4725
dc.identifier.pubmed29103292
dc.identifier.urihttps://hdl.handle.net/11424/220247
dc.identifier.wosWOS:000428136400012
dc.language.isoeng
dc.publisherEDIZIONI MINERVA MEDICA
dc.relation.ispartofMINERVA CARDIOANGIOLOGICA
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAortic valve stenosis
dc.subjectBioprosthesis
dc.subjectTranscatheter aortic valve replacement
dc.subjectRIGHT ANTERIOR MINITHORACOTOMY
dc.subjectHIGH-RISK PATIENTS
dc.subjectHEART-VALVE
dc.subjectCONDUCTION DISORDERS
dc.subjectCONVENTIONAL SURGERY
dc.subjectPERCEVAL VALVE
dc.subjectSINGLE-CENTER
dc.subjectPILOT TRIAL
dc.subjectFOLLOW-UP
dc.subjectTRANSCATHETER
dc.titleThe future of surgical aortic valve replacement and the role of sutureless technology
dc.typereview
dspace.entity.typePublication
oaire.citation.endPage220
oaire.citation.issue2
oaire.citation.startPage213
oaire.citation.titleMINERVA CARDIOANGIOLOGICA
oaire.citation.volume66

Files